产品名称 | NebuSelect™ Recombinant Human IL-7R alpha/CD127, hFc-tag |
---|---|
目录号 | NBL-242467 |
别名 | IL-7R alpha/CD127; IL-17R alpha; IL7Ra; CD127; CDW127; ILRA |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P16871-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242467-100ug | 100ug | Inquire | Inquire | |
NBL-242467-1mg | 1mg | Inquire | Inquire | |
NBL-242467-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human IL-7R alpha/CD127, hFc-tag
Catalog#:
NBL-242467
Description:
NebuSelect™ Recombinant Human IL-7R alpha/CD127, hFc-tag(Cat#NBL-242467) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Glu21-Gly236.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 51.6 kDa. Due to glycosylation, the protein migrates to 65-75 kDa based on Bis-Tris PAGE result.
Target Name:
IL-7R alpha/CD127; IL-17R alpha; IL7Ra; CD127; CDW127; ILRA
Target Information:
Interleukin 7 (IL-7) and its receptor (IL-7R, a heterodimer of IL-7Rα and γc) are essential for normal lymphoid development. IL-7 and IL-7R activate three main pathways: STAT5, PI3K/Akt/mTOR and MEK/Erk, ultimately leading to the promotion of leukemia cell viability, cell cycle progression and growth.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.